↓ Skip to main content

Cochrane Database of Systematic Reviews

Creatine for treating muscle disorders

Overview of attention for article published in Cochrane database of systematic reviews, June 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
5 news outlets
blogs
1 blog
twitter
11 X users
patent
2 patents
facebook
3 Facebook pages
wikipedia
2 Wikipedia pages
video
2 YouTube creators

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
285 Mendeley
Title
Creatine for treating muscle disorders
Published in
Cochrane database of systematic reviews, June 2013
DOI 10.1002/14651858.cd004760.pub4
Pubmed ID
Authors

Rudolf A Kley, Mark A Tarnopolsky, Matthias Vorgerd

Abstract

Progressive muscle weakness is a main symptom of most hereditary and acquired muscle diseases. Creatine improves muscle performance in healthy individuals. This is an update of our 2007 Cochrane review that evaluated creatine treatment in muscle disorders. Previous updates were in 2009 and 2011.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 285 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
United Kingdom 2 <1%
Ireland 1 <1%
Portugal 1 <1%
Canada 1 <1%
Germany 1 <1%
Unknown 276 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 41 14%
Student > Master 35 12%
Researcher 29 10%
Student > Bachelor 26 9%
Student > Doctoral Student 20 7%
Other 56 20%
Unknown 78 27%
Readers by discipline Count As %
Medicine and Dentistry 69 24%
Nursing and Health Professions 28 10%
Sports and Recreations 21 7%
Agricultural and Biological Sciences 20 7%
Biochemistry, Genetics and Molecular Biology 12 4%
Other 48 17%
Unknown 87 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2024.
All research outputs
#677,859
of 26,212,054 outputs
Outputs from Cochrane database of systematic reviews
#1,184
of 13,193 outputs
Outputs of similar age
#4,831
of 211,912 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 294 outputs
Altmetric has tracked 26,212,054 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,193 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,912 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 294 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.